733
edits
HIV and the Heart: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
''Tim P. van de Hoef, MD'' | |||
==Case Study== | ==Case Study== | ||
| Line 64: | Line 64: | ||
Clinical outcome after revascularization (predominantly for ACS) is similar for HIV-infected and non-infected populations, regardless of whether revascularization is performed percutaneously or surgically.<cite>55</cite><cite>56</cite> HIV-infected patients, however, do remain at increased risk for recurrent ACS during follow-up<cite>57</cite>, which is importantly associated with persistently elevated lipid spectra. | Clinical outcome after revascularization (predominantly for ACS) is similar for HIV-infected and non-infected populations, regardless of whether revascularization is performed percutaneously or surgically.<cite>55</cite><cite>56</cite> HIV-infected patients, however, do remain at increased risk for recurrent ACS during follow-up<cite>57</cite>, which is importantly associated with persistently elevated lipid spectra. | ||
{| class="wikitable | {| class="wikitable" | ||
|- | |- | ||
!Key Points: | !Key Points: | ||